rs2234581

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001429031.1(WT1):​c.-39C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000073 in 1,369,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 7.3e-7 ( 0 hom. )

Consequence

WT1
NM_001429031.1 5_prime_UTR_premature_start_codon_gain

Scores

3
2
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.14

Publications

0 publications found
Variant links:
Genes affected
WT1 (HGNC:12796): (WT1 transcription factor) This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015]
WT1-AS (HGNC:18135): (WT1 antisense RNA) This gene is located upstream of the Wilms tumor 1 (WT1) gene; these two genes are bi-directionally transcribed from the same promoter region. This gene is imprinted in kidney, with preferential expression from the paternal allele. Imprinting defects at chromosome 11p13 may contribute to tumorigenesis. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14501125).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001429031.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WT1
NM_024426.6
MANE Select
c.181C>Tp.Arg61Trp
missense
Exon 1 of 10NP_077744.4
WT1
NM_001429031.1
c.-39C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 10NP_001415960.1P19544-1
WT1
NM_001429032.1
c.-39C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 10NP_001415961.1P19544-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WT1
ENST00000452863.10
TSL:1 MANE Select
c.181C>Tp.Arg61Trp
missense
Exon 1 of 10ENSP00000415516.5P19544-7
WT1
ENST00000639563.4
TSL:1
c.181C>Tp.Arg61Trp
missense
Exon 1 of 9ENSP00000492269.3P19544-8
WT1
ENST00000332351.9
TSL:1
c.181C>Tp.Arg61Trp
missense
Exon 1 of 9ENSP00000331327.5J3KNN9

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
AF:
7.30e-7
AC:
1
AN:
1369648
Hom.:
0
Cov.:
44
AF XY:
0.00
AC XY:
0
AN XY:
674532
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30284
American (AMR)
AF:
0.00
AC:
0
AN:
34594
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24526
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34852
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78176
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33308
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4770
European-Non Finnish (NFE)
AF:
9.33e-7
AC:
1
AN:
1072130
Other (OTH)
AF:
0.00
AC:
0
AN:
57008
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
30

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
11p partial monosomy syndrome;C0950121:Drash syndrome;C0950122:Frasier syndrome;CN033288:Wilms tumor 1 (1)
-
1
-
Wilms tumor 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.63
CADD
Uncertain
24
DANN
Uncertain
1.0
Eigen
Benign
-0.95
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.49
N
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.15
T
MetaSVM
Benign
-1.0
T
PhyloP100
2.1
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-0.69
N
REVEL
Benign
0.070
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Vest4
0.21
MutPred
0.22
Loss of methylation at R59 (P = 0.0316)
MVP
0.13
ClinPred
0.71
D
GERP RS
2.2
PromoterAI
-0.022
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2234581; hg19: chr11-32456726; COSMIC: COSV60084444; COSMIC: COSV60084444; API